Bee pollen is produced by honeybees and is considered one of the most balanced and nourishing nutritional supplements available. Historically, bee pollen has been prescribed for its healing properties and consumed for its high-energy supply. Recent research has provided evidence that bee pollen has diverse biological activities, such as anti-oxidant, anti-inflammatory, anti-bacterial, and even anti-cancer effects. However, the outer membrane of the pollen grain, exine, is highly resistant to most acidic solutions, high pressure, and even digestive enzymes, and the resulting low bioavailability limits its nutritional and clinical applications. This study applied a wet-grinding method to destroy the exine effectively, and it then examined the pollen's enhanced biological activity. First, microscopic observations provided strong evidence that wet grinding destroyed the exine time-dependently. In addition, the content of polyphenols, well-known ingredients of bee pollen and used as internal standards for the quality control of commercial pollen preparations, increased up to 11-fold with wet grinding. Further, the anti-oxidant activity demonstrated on the ABTS anti-oxidant assay, as well as the DPPH radical scavenging assay, was also dramatically increased. Together, the results presented here support a new technology by which bee pollen can be used as a resource for medical, nutritional, and cosmetic applications.
Bee pollen is a valuable apitherapeutic product greatly appreciated by the natural medicine because of its potential medical and nutritional applications. It demonstrates a series of actions such as antifungal, antimicrobial, antiviral, anti-inflammatory, hepatoprotective, anticancer immunostimulating, and local analgesic. Its radical scavenging potential has also been reported. Beneficial properties of bee pollen and the validity for their therapeutic use in various pathological condition have been discussed in this study and with the currently known mechanisms, by which bee pollen modulates burn wound healing process.
Purpose: In a previous study, we identified the skin-whitening effect of the ethanolic extract of Padina gymnospora. The present study was performed to confirm the safety of the extract in animal replacement tests.Methods: To evaluate the safety of the extract of Padina gymnospora, the photosensitivity test (Harber test), in vitro 3T3 neutral red uptake (3T3 NRU) phototoxicity test, local lymph node assay (5-bromo-2'-deoxyuridine enzyme-linked immunosorbent assay), acute oral toxicity test, and reconstructed human epidermis (RHE) test were used. All experiments followed the guidelines of the Korean Ministry of Food and Drug Safety and were conducted by a GLP-certified organization (Chemon Inc.).Results: The extract of Padina gymnospora was not photosensitive: 0% photosensitization was detected (I grade: very weak). In the 3T3 NRU phototoxicity test, the relative viability of the extract-treated cells was higher than the guideline level; thus, the extract was classified as non-phototoxic. Treatment with the extract did not trigger skin irritation in the RHE test model and did not cause skin sensitization in the local lymph node assay. Finally, oral administration of the extract to rats indicated that it was not a harmful material as the LD50 was estimated at >2,000 mg/kg.Conclusion: The ethanolic extract of Padina gymnospora was demonstrated to be safe when applied to the skin. Taken together with our previous study of its efficacy, we conclude that this extract has the potential for use as a cosmetic ingredient.
BackgroundThe accumulation of lipoprotein and monocyte in the intima of the arterial wall is the most important step of the development of coronary artery disease CAD . Lipoprotein lipase LPL plays an antiatherogenic role by lipolysis of triglyceride-rich lipoproteins, but, it may also act as a receptor of some lipoproteins and monocyte at the arterial wall and act as a atherogenic molecule. Previous studies showed somewhat contradictory results about the association of CAD and LPL polymorphisms and mutations. Racial and dietary difference may contribute to these contradictory results. In this study, we tried to find out the association of CAD and the genetic variation of the LPL Pvu RFLP in intron 6, Hind RFLP in intron 8 and Ser 447 Ter mutation in exon 9 in Korean population. Method and Result CAD patients n 146 , confirmed by coronary angiography and healthy Korean adult volunteers n 110 were genotyped for Pvu Hind RFLP and Ser447Ter mutation of the LPL gene by PCR-digestion method. Between two groups, the genotype frequency of these genetic variations was not different. But, the genetic variations showed different effect on lipid profile and body mass index BMI in the CAD group and in the control group. In the CAD group, P1 allele carriers showed higher total cholesterol P1P1 P1P2 P2P2 216 51 mg dl 198 38 mg dl, p 0.039 and higher LDL cholesterol level P1P1 P1P2 P2P2 143 46 mg dl 126 36 mg dl, p 0.047 , and H1 allele carriers had lower Body mass index than non-carriers 23.8 2.3 kg m
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.